Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018

  • Report
  • 159 Pages
From
Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Gastrointestinal Bleeding (Gastrointestinal Hemorrhage) Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 117 Pages
From
Gastroparesis Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Gastroparesis Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 102 Pages
From
Diabetic Gastroparesis Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Diabetic Gastroparesis Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 65 Pages
From
Hepatic Encephalopathy Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Hepatic Encephalopathy Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 107 Pages
From
Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2018 - Product Thumbnail Image

Liver Failure (Hepatic Insufficiency) - Pipeline Review, H1 2018

  • Report
  • 101 Pages
From
Liver Cirrhosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Liver Cirrhosis - Pipeline Review, H1 2018

  • Report
  • 88 Pages
From
Liver Failure - Pipeline Insight, 2018 - Product Thumbnail Image

Liver Failure - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Hepatic Encephalopathy - Pipeline Review, H2 2018 - Product Thumbnail Image

Hepatic Encephalopathy - Pipeline Review, H2 2018

  • Report
  • 72 Pages
From
Liver Cirrhosis Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Liver Cirrhosis Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 300 Pages
From
Hepatic Encephalopathy - Pipeline Insight, 2018 - Product Thumbnail Image

Hepatic Encephalopathy - Pipeline Insight, 2018

  • Drug Pipelines
  • 50 Pages
From
Hyperammonemia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Hyperammonemia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 43 Pages
From
Hepatic Injury Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Hepatic Injury Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 56 Pages
From
Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Irritable Bowel Syndrome (IBS) Therapeutics - Global Strategic Business Report

  • Report
  • 433 Pages
From
Ocera Therapeutics Inc (OCRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Ocera Therapeutics Inc (OCRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • 84 Pages
From
Ocera Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report - Product Thumbnail Image

Ocera Therapeutics Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • Mergers and Acquisitions Profiles
  • 65 Pages
From
Ocera Therapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report - Product Thumbnail Image

Ocera Therapeutics Inc Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

  • Financial Report
  • 35 Pages
From
Ocera Therapeutics Inc - Product Thumbnail Image

Ocera Therapeutics Inc

  • Company Profile
  • 68 Pages
Ocera Therapeutics Inc Strategic Analysis Review - Ocera Therapeutics Inc SWOT, Outlook, Operations and Financial Profile - Product Thumbnail Image

Ocera Therapeutics Inc Strategic Analysis Review - Ocera Therapeutics Inc SWOT, Outlook, Operations and Financial Profile

  • Company Profile
  • 30 Pages
From
Ocera Therapeutics, Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Ocera Therapeutics, Inc. Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 20 Results (Page 1 of 1)
Loading Indicator
adroll